Holen Sie sich die Stockscreener-App
1.26
0.00%
0.00
Handel nachbörslich:
1.25
-0.01
-0.79%
Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
37.45%
7.216
|
11.54 | 8.598 | 14.01 | 15.88 |
| Operating Income/Loss |
37.45%
-7.216
|
-11.54 | -8.598 | -14.01 | -15.88 |
| Income/Loss From Continuing Operations Before Tax |
39.32%
-6.462
|
-10.65 | -7.522 | -12.75 | -14.44 |
| Income/Loss From Continuing Operations After Tax |
39.32%
-6.462
|
-10.65 | -7.522 | -12.75 | -14.44 |
|
Net Income/Loss
|
39.32%
-6.462
|
-10.65 | -7.522 | -12.75 | -14.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | 0.001 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | -0.001 | - | - |
| Basic Average Shares |
0.39%
30.17
|
30.05 | 0.0184 | 29.84 | 29.82 |
| Diluted Average Shares |
0.39%
30.17
|
30.05 | 0.0184 | 29.84 | 29.82 |
| Basic Earnings Per Share |
40.00%
-0.21
|
-0.35 | -0.25 | -0.43 | -0.48 |
| Diluted Earnings Per Share |
40.00%
-0.21
|
-0.35 | -0.25 | -0.43 | -0.48 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | 0.001 | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):